CIK 0001682639 · Non-accelerated filer<br>Smaller reporting company
HYPERION DEFI, INC.
Sign in to watch- Ticker
- HYPD
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471178401
- Phone
- 833-393-6684
- Business address
- 3090 NOWITZKI WAY, SUITE 300, DALLAS, TX, 75219
- Former names
- EYENOVIA, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 5 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-07-11 | Ianchulev Tsontcho Chief Executive Officer | Purchase | +233,813 | $2.78 | $650K | 426,248 |
| 2019-05-14 | Yoshida Shuhei Director | Option exercise | +33,334 | $1.95 | $65K | 33,334 |
| 2019-05-14 | Yoshida Shuhei Director | Option exercise · Stock Option (right to buy) | −33,334 | 0 | ||
| 2019-01-02 | LaBelle Curt H Director | Option exercise | +140,000 | $1.24 | $174K | 606,667 |
| 2019-01-02 | LaBelle Curt H Director | Option exercise · Stock Option (right to buy) | −140,000 | 140,000 | ||
| 2019-01-02 | Ianchulev Tsontcho Chief Executive Officer | Option exercise | +40,000 | $1.24 | $50K | 58,749 |
| 2019-01-02 | Ianchulev Tsontcho Chief Executive Officer | Option exercise | +133,686 | $1.95 | $261K | 192,435 |
| 2019-01-02 | Ianchulev Tsontcho Chief Executive Officer | Option exercise | +140,000 | $1.24 | $174K | 606,667 |
| 2019-01-02 | Ianchulev Tsontcho Chief Executive Officer | Option exercise · Stock Option (right to buy) | −40,000 | 0 | ||
| 2019-01-02 | Ianchulev Tsontcho Chief Executive Officer | Option exercise · Stock Option (right to buy) | −133,686 | 267,370 | ||
| 2019-01-02 | Ianchulev Tsontcho Chief Executive Officer | Option exercise · Stock Option (right to buy) | −140,000 | 140,000 | ||
| 2018-09-25 | Rowe Michael M Vice President of Marketing | Purchase | +600 | $4.27 | $3K | 1,000 |
| 2018-09-24 | Rowe Michael M Vice President of Marketing | Purchase | +200 | $4.09 | $818 | 400 |
| 2018-09-19 | MATHER CHARLES E IV Director | Purchase | +3,000 | $4.78 | $14K | 8,033 |
| 2018-09-18 | MATHER CHARLES E IV Director | Purchase | +1,000 | $4.80 | $5K | 5,033 |
| 2018-09-10 | Clasby Jennifer G VP, Clinical Operations | Option exercise | +28,965 | $1.95 | $56K | 28,965 |
| 2018-09-10 | Clasby Jennifer G VP, Clinical Operations | Option exercise · Stock Option (right to buy) | +28,965 | 51,247 | ||
| 2018-07-24 | SUN ANTHONY Y Director | Grant or award | +4,033 | 4,033 | ||
| 2018-07-24 | SUN ANTHONY Y Director | Grant or award · Stock Option (right to buy) | +4,465 | 4,465 | ||
| 2018-07-24 | MARIO ERNEST Director | Grant or award | +4,033 | 146,770 |
Page 15 of 16 · 317 trades